Pediatric Cancer
Investigators from the hospital's D3b program are leading development of what aims to be the largest clinically annotated pediatric brain tumor cohort study to date.
Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests
Research presented at ASHG suggested that germline cancer susceptibility profiling may help to predict survival outcomes for a subset of rhabdomyosarcoma cases.
Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer
The analysis also found that about half the sibling deaths due to cancer could be averted by surveillance following cascade testing, as compared to usual care.
Molecular Profiling in Pediatric Cancer Trials Continues to Prove Valuable for Treatment Matching
Premium
The GAIN/iCat2 study and the Pediatric MATCH trial showed that molecular data has a significant impact on treatment recommendations for kids with cancer.
The liquid biopsy method analyzes fragment ends within recurrently protected regions in cell-free DNA from a patient's urine sample.